Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients

Imbalanced immune responses are involved in developing preeclampsia (PE). We wish to explore the expression and potential changes of immune checkpoint molecules TIGIT, CD226 and CD155 in PE patients.

Source: BMC Immunology - February 7, 2024 Category: Allergy & Immunology Authors: Cui Li, Haiyan Liu and Zhongliang Duan Tags: Research Source Type: research